MDVN Insider Trading Activity and SEC Form 4 Filings
MDVN insider trading summary
No open-market insider purchases or sales of Medivation, Inc. (MDVN) have been reported on SEC Form 4 in the past 12 months.
Latest MDVN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 6, 2016 | Andrew Kenneth William Powell | SVP, General Counsel & Crp Sec | Sell | $156K (2,578 @ $60.42) |
| May 6, 2016 | Rick Bierly | CFO (former) | Sell | $24K (400 @ $60.66) |
| May 6, 2016 | Rick Bierly | CFO (former) | Sell | $355K (5,915 @ $60.08) |
| May 5, 2016 | Rick Bierly | CFO (former) | Sell | $238K (4,025 @ $59.20) |
| Mar 14, 2016 | Dawn Svoronos | Director | Sell | $233K (6,000 @ $38.90) |
| Mar 4, 2016 | David Hung | President and CEO | Sell | $209K (5,085 @ $41.10) |
| Mar 4, 2016 | Rick Bierly | Chief Financial Officer | Sell | $75K (1,875 @ $40.00) |
| Mar 4, 2016 | Rick Bierly | Chief Financial Officer | Sell | $45K (1,123 @ $40.00) |
| Mar 4, 2016 | Mohammad Hirmand | Interim Chief Medical Officer | Sell | $63K (1,525 @ $41.10) |
| Feb 4, 2016 | David Hung | President and CEO | Sell | $198K (6,350 @ $31.18) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.